ESC 365 - Antithrombotic therapy after INFRA - Popliteal stenting for critical limb-threatening ischemia - What do the guidelines say?

ESC Premium Access

Antithrombotic therapy after INFRA - Popliteal stenting for critical limb-threatening ischemia - What do the guidelines say?

Session: Antithrombotic therapy in patients with lower extremity arterial disease

Topic: Pharmacotherapy

Speaker: Professor J. Collet (Paris, FR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Jean-Philippe Collet

Pitie Salpetriere APHP University Hospital, Paris (France)

23 presentations

0 follower

7 more presentations in this session

Case 1: Antithrombotic therapy in a 50 year old patient with intermittent claudication.

Speaker: Professor E. Messas (Paris, FR)

Antithrombotic therapy in a 50 year old patient with intermittent claudication - What do the guidelines say?

Speaker: Professor C. Espinola-Klein (Mainz, DE)

Antithrombotic therapy in a 50 year old patient with intermittent claudication - How to implement the Guidelines.

Antithrombotic therapy in a 50 year old patient with intermittent claudication.- Conclusion and take home message.

Speaker: Professor M. Brodmann (Graz, AT)

Case 2: Antithrombotic therapy after INFRA - Popliteal stenting for critical limb-threatening ischemia

Speaker: Associate Professor M. De Carlo (Pisa, IT)

Access the full session

Antithrombotic therapy in patients with lower extremity arterial disease

Speakers: Professor J. Collet, Professor E. Messas, Professor C. Espinola-Klein, Professor M. Brodmann, Associate Professor M. De Carlo

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources